Fulcrum Therapeutics

169 articles about Fulcrum Therapeutics

• 

  Fulcrum Therapeutics Raises $80 Million Series B From Investors, Including Sanofi and Bill Maris'...

  9/5/2018

  Fulcrum Therapeutics, based in Cambridge, Massachusetts, closed on an $80 million Series B financing.

• Fulcrum Therapeutics Announces Additional Series A Financing From GV

  5/10/2017

• Fulcrum Therapeutics Expands Leadership Team With Appointment Of Owen Wallace, Ph.D., As Chief Scientific Officer And Amit Hasija As Chief Business Officer

  5/3/2017

• Fulcrum Therapeutics Strengthens Its Board Of Directors With The Addition Of Alan Ezekowitz, MBChB, D.Phil., And James J. Collins, Ph.D.

  2/7/2017

• What You Need to Know About Fulcrum Therapeutics

  1/23/2017

• 

  The Next Generation: Top 20 Life Science Startups to Watch in 2017

  1/9/2017

  BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.

• Fulcrum Therapeutics Appoints Renowned Experts In CNS Disorders And Muscular Dystrophies To Serve On Newly Formed Scientific Advisory Board

  12/7/2016

• Horizon Discovery Ltd. And Fulcrum Therapeutics Form Collaboration For Novel CRISPR-Based Target Discovery In Genetic Diseases

  9/6/2016

• Former Epizyme CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A

  7/19/2016